EUVIMEDEUVIMED entdecken
Crossref

Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment

Katja C Heinz iD, Charlotte Beaudart iD, Axel De Greef iD, Olivier Vanhooteghem, Antoni Gostynski, Mickaël Hiligsmann iD

Expert Review of Pharmacoeconomics & Outcomes Research · 2026

DOI: 10.1080/14737167.2025.2594633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2026. Verfasst von Katja C Heinz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Patient Preference, Quality of Life, Choice Behavior. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Atopic dermatitis (AD) is a chronic skin disease that affects patients' quality of life. Adequate treatment is important but patients' preferences are not fully understood. This study aimed to investigate which treatment attributes are most important for adult European AD patients. RESEARCH DESIGN AND METHODS: A discrete choice experiment was conducted. Participants were asked to choose their preferred hypothetical treatment option in 15 choice sets. Six included attributes were identified by consulting literature, patients, physicians, and preference experts. A mixed logit model was applied to estimate preference coefficients. RESULTS: All attributes were important for seventy-five participants (79% female, mean age 37.8 years). Itch reduction was most relevant (55.95%), followed by infection risk (15.96%), mode of administration (9.64%), long-term diseases management (8.11%), onset time (5.33%), and availability on the market (5.01%). Participants prefer emollients without preservatives and oral pills, while emollients with preservatives and self-injections are associated with utility loss. CONCLUSIONS: This study identified most important treatment attributes for AD patients. It could improve AD patients' access to suitable therapies as findings might support development of better aligned treatments and provide new perspectives for joint treatment decision-making. Main limitation was low number of participants, although significant results were still achieved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicPatient PreferenceQuality of LifeChoice BehaviorDermatologic AgentsHumansFemaleAdultMaleEuropeMiddle AgedYoung AdultLogistic ModelsPruritusEmollients

Stichwörter der Autor:innen

Atopic dermatitisdiscrete choice experimenteczemapatient preferencespreference research

Substanzen

EmollientsDermatologic Agents

Autor:innen und Institutionen

  • Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Public Health Aging Research & Epidemiology (PHARE) Group, Research Unit in Clinical Pharmacology and Toxicology (URPC), NAmur Research Institute for LIfe Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Department of Dermatology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Institute of Experimental and Clinical Research (IREC), Pneumology, ENT and Dermatology Pole (LUNS), Université catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Department of Dermatology, CHU UCL Namur - Sainte Elisabeth, Namur, Belgium.
  • Department of Dermatology, Maastricht University Medical Centre+, Maastricht, The Netherlands; GROW - Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.

ORCID-Profile: Katja C Heinz, Charlotte Beaudart, Axel De Greef, Mickaël Hiligsmann

Zitieren

APA

Heinz, K. C., Beaudart, C., De Greef, A., Vanhooteghem, O., Gostynski, A., & Hiligsmann, M. (2026). Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2594633

Vancouver

Heinz KC, Beaudart C, De Greef A, Vanhooteghem O, Gostynski A, Hiligsmann M. Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment. Expert Review of Pharmacoeconomics & Outcomes Research. 2026. doi:10.1080/14737167.2025.2594633

BibTeX
@article{Heinz2026,
  author = {Heinz, Katja C and Beaudart, Charlotte and De Greef, Axel and Vanhooteghem, Olivier and Gostynski, Antoni and Hiligsmann, Mickaël},
  title = {Patients’ preferences for atopic dermatitis treatments in Europe: a discrete choice experiment},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2026},
  doi = {10.1080/14737167.2025.2594633}
}
Kostenlos starten →